Septerna CPO exercises options, sells 11,798 shares
Septerna, Inc. Chief People Officer Samira Shaikhly reported an option exercise and related share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Septerna, Inc. Chief People Officer Samira Shaikhly reported an option exercise and related share sale. She exercised stock options to acquire 11,798 shares of common stock at an exercise price of $6.81 per share, then sold 11,798 shares in open-market transactions at a weighted average price of $30.0607 per share.
The sales were made under a pre-arranged Rule 10b5-1 sales plan adopted on October 31, 2025, and executed in multiple trades between $30.00 and $30.24 per share. After these transactions, she directly owned 793 shares of Septerna common stock.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 11,798 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,798 | $6.81 | $80K |
| Sale | Common Stock | 11,798 | $30.0607 | $355K |
Footnotes (3)
- F1. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 31, 2025.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
Key Figures
Key Terms
Rule 10b5-1 sales plan regulatory
weighted average price financial
Stock Option (Right to Buy) financial
exercise or conversion of derivative security financial
vest and become exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Septerna (SEPN) report for Samira Shaikhly?
What was the option exercise price in the Septerna (SEPN) Form 4 filing?
Was the Septerna (SEPN) insider sale under a Rule 10b5-1 plan?
What are the key terms of the stock option in Septerna (SEPN)’s Form 4?
How does the Septerna (SEPN) Form 4 describe vesting of the option?
AI-generated analysis. How Rhea-AI works. Not financial advice.